Distributing since 1889 • Employee Owned for Better Service

Your 1st Choice!

Quick Search:

Cart | My Account | View Printable Page

Product Detail

NOTICE: This is the ProQuest Ebook Centralï¿½ format of this title. What is ProQuest Ebook Centralï¿½?

Other formats:

All Formats

Nelson's Pediatric Antimicrobial Therapy 2022

Bradley, John S. MD

Pricing & Availability
Available: Yes*
This title does not qualify for any discount.

Other formats:

Book Information
Edition:	28th
Publisher:	American Academy of Pediatrics
ISBN:	1-61002-565-2 (1610025652)
ISBN-13:	978-1-61002-565-2 (9781610025652)
Format:	Hndbk/Pktbk/Tables
Binding:	E E Book + ProQuest Ebook Central
Copyright:	2022
Publish Date:	03/22
Volume:	2022
Weight:	0.00 Lbs.
Subject Class:	RET (Returns)
Remarks:	A New Edition of this Title is Available
Return Policy:	Non-Returnable.

ProQuest Ebook Centralï¿½:	Please sign in to preview this title

Class Specifications
ISSN Series:	Nelson's Pediatric Antimicrobial Therapy
Discipline:	Pharmacology
Subject Definition:	Antibiotics-Therapeutic Use-Handbooks; Child
NLM Class:	QV 39
LC Class:	RJ53
Abstract:	Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections.Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021.."2022.Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase.."producing enteric bacilli, if susceptible.

* Subject to ProQuest Ebook Centralï¿½ availability

Follow Matthews Book Co. on: